• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠中,暂时性门静脉栓塞与永久性门静脉栓塞的效果相同。

Temporary portal vein embolization is as efficient as permanent portal vein embolization in mice.

作者信息

Wirsching Andrea, Melloul Emmanuel, Lezhnina Ksenia, Buzdin Anton A, Ogunshola Omolara O, Borger Pieter, Clavien Pierre-Alain, Lesurtel Mickaël

机构信息

Swiss Hepato-Pancreatico-Biliary and Transplantation Center, Department of Surgery, University Hospital Zurich, Zürich, Switzerland.

Department of Visceral Surgery, University Hospital Lausanne, Lausanne, Switzerland.

出版信息

Surgery. 2017 Jul;162(1):68-81. doi: 10.1016/j.surg.2017.01.032. Epub 2017 Apr 14.

DOI:10.1016/j.surg.2017.01.032
PMID:28413066
Abstract

BACKGROUND

Temporary portal vein embolization may be a safe alternative to permanent portal vein embolization. Such a new approach could be applied in living-related liver transplantation to increase graft volume before procurement. The impact of temporary portal vein embolization on occluded liver after recanalization, however, has never been assessed. Using a mouse model of temporary portal vein embolization, we investigated (1) the efficiency of temporary portal vein embolization in inducing nonoccluded liver hypertrophy and (2) the regeneration potential and functional recovery of embolized liver after recanalization.

METHODS

Selected portal vein branches were occluded using gelfoam powder (temporary portal vein embolization) or embospheres (permanent portal vein embolization), n = 5/group. Magnetic resonance volumetry and angiography were used to determine volumes of the liver lobe and portal vein branch recanalization. In order to assess the functional and regenerative capacity of occluded liver lobes, nonoccluded lobes were resected 14 days (timespan of complete portal vein recanalization) after temporary portal vein embolization or permanent portal vein embolization. Subsequently, RNA sequencing was performed to compare the signaling pathways of early liver regeneration among the groups.

RESULTS

Hypertrophy of nonoccluded lobes 30 days after temporary portal vein embolization and permanent portal vein embolization was similar (103 ± 26% and 129 ± 13%, P = .11). Temporary occluded lobes increased their volumes after nonoccluded lobes resection, reaching similar liver-to-body-weight ratios and similar functional capacity after 7 days compared with partial hepatectomy controls (4 ± 1% vs 4 ± 1%, P = .22). Partial hepatectomy activated similar signaling pathways in temporary occluded and native liver.

CONCLUSION

Temporary portal vein embolization induces hypertrophy of contralateral liver lobes similarly to permanent portal vein embolization in mice. This experimental work suggests that temporary portal vein embolization may be considered as a possibility in living liver donation, because regenerative and functional capacities are preserved in the embolized liver after recanalization in mice.

摘要

背景

临时门静脉栓塞可能是永久性门静脉栓塞的一种安全替代方法。这种新方法可应用于活体肝移植,以在获取供肝前增加移植肝体积。然而,临时门静脉栓塞再通后对被栓塞肝脏的影响尚未得到评估。我们使用临时门静脉栓塞的小鼠模型,研究了(1)临时门静脉栓塞诱导非栓塞侧肝脏肥大的效率,以及(2)再通后栓塞肝脏的再生潜力和功能恢复情况。

方法

使用明胶海绵粉末(临时门静脉栓塞)或栓塞微球(永久性门静脉栓塞)闭塞选定的门静脉分支,每组n = 5只。采用磁共振容积测量和血管造影来确定肝叶体积和门静脉分支再通情况。为了评估被栓塞肝叶的功能和再生能力,在临时门静脉栓塞或永久性门静脉栓塞后14天(门静脉完全再通的时间跨度)切除非栓塞肝叶。随后,进行RNA测序以比较各组早期肝再生的信号通路。

结果

临时门静脉栓塞和永久性门静脉栓塞后30天,非栓塞肝叶的肥大情况相似(分别为103±26%和129±13%,P = 0.11)。在切除非栓塞肝叶后,临时被栓塞的肝叶体积增加,与部分肝切除对照组相比,7天后达到相似的肝体重比和相似的功能能力(分别为4±1%和4±1%,P = 0.22)。部分肝切除术在临时被栓塞的肝脏和正常肝脏中激活了相似的信号通路。

结论

在小鼠中,临时门静脉栓塞与永久性门静脉栓塞一样能诱导对侧肝叶肥大。这项实验研究表明,临时门静脉栓塞在活体肝捐赠中可能是一种可行的方法,因为在小鼠再通后,被栓塞肝脏的再生和功能能力得以保留。

相似文献

1
Temporary portal vein embolization is as efficient as permanent portal vein embolization in mice.在小鼠中,暂时性门静脉栓塞与永久性门静脉栓塞的效果相同。
Surgery. 2017 Jul;162(1):68-81. doi: 10.1016/j.surg.2017.01.032. Epub 2017 Apr 14.
2
Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model.兔模型中应用可吸收和永久性栓塞材料行门静脉栓塞后的肝脏再生。
Ann Surg. 2012 Feb;255(2):311-8. doi: 10.1097/SLA.0b013e31823e7587.
3
Use of an absorbable embolization material for reversible portal vein embolization in an experimental model.使用可吸收栓塞材料进行实验模型中的可复性门静脉栓塞。
Br J Surg. 2016 Sep;103(10):1306-15. doi: 10.1002/bjs.10208. Epub 2016 Aug 1.
4
Portal vein embolization induces compensatory hypertrophy of remnant liver.门静脉栓塞可诱导残余肝脏的代偿性肥大。
World J Gastroenterol. 2006 Jan 21;12(3):408-14. doi: 10.3748/wjg.v12.i3.408.
5
Liver regeneration and recanalization time course following reversible portal vein embolization.可逆性门静脉栓塞术后肝脏再生和再通的时间进程
J Hepatol. 2008 Sep;49(3):354-62. doi: 10.1016/j.jhep.2008.01.034. Epub 2008 Mar 10.
6
Liver regeneration following repeated reversible portal vein embolization in an experimental model.实验模型中重复可逆门静脉栓塞后肝脏再生。
Br J Surg. 2016 Aug;103(9):1209-19. doi: 10.1002/bjs.10153. Epub 2016 Jun 3.
7
Experimental and clinical studies on liver regeneration following transcatheter portal embolization.经导管门静脉栓塞术后肝脏再生的实验与临床研究
Hepatogastroenterology. 2000 Jan-Feb;47(31):226-33.
8
Liver Regeneration and Recanalization Time Course following Repeated Reversible Portal Vein Embolization in Swine.猪反复可复性门静脉栓塞后肝再生和再通时间过程。
Eur Surg Res. 2020;61(2-3):62-71. doi: 10.1159/000509713. Epub 2020 Oct 13.
9
Efficient liver regeneration following temporary portal vein embolization with absorbable gelatin sponge powder in humans.人使用可吸收明胶海绵粉进行暂时性门静脉栓塞后有效的肝脏再生
J Vasc Interv Radiol. 2015 Apr;26(4):507-15. doi: 10.1016/j.jvir.2014.11.033. Epub 2015 Jan 29.
10
Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?肝切除术后和门静脉栓塞(结扎)后的肝再生机制不同吗?
J Hepatobiliary Pancreat Surg. 2009;16(3):292-9. doi: 10.1007/s00534-009-0058-x. Epub 2009 Mar 31.

引用本文的文献

1
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs.基于通路的突变数据分析对癌症靶向药物评分很有效。
Front Pharmacol. 2019 Jan 23;10:1. doi: 10.3389/fphar.2019.00001. eCollection 2019.